Medigen Vaccine Biologics Corp (MVC) has signed a regional distribution agreement with the pharmaceutical company Substipharm Biologics to expand the market reach of enterovirus vaccine products in ...

Credit: Komsan Loonprom/Shutterstock. Astellas Pharma and Sangamo Therapeutics have signed a licence agreement for a neurotropic adeno-associated virus (AAV) capsid, STAC-BBB, aimed at treating ...

Stock futures edged higher on Thursday, rebounding from the previous session’s losses, as the Federal Reserve forecasted persistent inflation and limited rate cuts in 2025. The outlook followed ...

U.S. stock futures climbed on Thursday in premarket hours after the indices declined in the previous session following a hawkish cut from the Federal Reserve. The futures of all four major indices ...

The agreement grants the Japanese pharma the worldwide license to initially use Sangamo's proprietary neurotropic adeno-associated virus (AAV) capsid, dubbed STAC-BBB, for one target. The idea is ...